BDX (STOCKS)
Becton, Dickinson and Co.
$155.430000
+1.210000 (+0.78%)
Prev close: $154.220000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Thomas E. Polen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44,248.91M
- Employees
- 74,000
- P/E (TTM)
- 25.19
- P/B (TTM)
- 1.74
- Dividend Yield
- 271.04%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $21.92B |
| Benefits Costs and Expenses | $19.96B |
| Cost Of Revenue | $11.82B |
| Costs And Expenses | $19.25B |
| Gross Profit | $10.10B |
| Operating Expenses | $7.42B |
| Selling, General, and Administrative Expenses | $5.35B |
| Research and Development | $1.23B |
| Other Operating Expenses | $845.00M |
| Operating Income/Loss | $2.68B |
| Income/Loss From Continuing Operations After Tax | $1.76B |
| Income/Loss From Continuing Operations Before Tax | $1.97B |
| Income Tax Expense/Benefit | $212.00M |
| Net Income/Loss | $1.76B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.76B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.76B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.13 |
| Diluted Earnings Per Share | $6.13 |
| Basic Average Shares | 859,696,000 |
| Diluted Average Shares | 860,621,000 |
| Assets | $54.84B |
| Current Assets | $9.19B |
| Inventory | $4.09B |
| Other Current Assets | $5.10B |
| Noncurrent Assets | $45.65B |
| Fixed Assets | $6.97B |
| Other Non-current Assets | $38.68B |
| Liabilities | $29.56B |
| Current Liabilities | $8.76B |
| Noncurrent Liabilities | $20.80B |
| Equity | $25.28B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $25.28B |
| Liabilities And Equity | $54.84B |
| Net Cash Flow From Operating Activities | $3.39B |
| Net Cash Flow From Operating Activities, Continuing | $3.39B |
| Net Cash Flow From Investing Activities | -$1.21B |
| Net Cash Flow From Investing Activities, Continuing | -$1.21B |
| Net Cash Flow From Financing Activities | -$1.99B |
| Net Cash Flow From Financing Activities, Continuing | -$1.99B |
| Exchange Gains/Losses | $14.00M |
| Net Cash Flow | $212.00M |
| Net Cash Flow, Continuing | $198.00M |
| Comprehensive Income/Loss | $1.58B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.58B |
| Other Comprehensive Income/Loss | -$181.00M |